A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Clinical trial NCT02725268 · COMPLETED

Trial details

NCT number: NCT02725268
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms

Start date: 2016-04-01
Primary completion: 2019-07-02
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.